
PBPK Modeling & MIDD: Simcyp vs GastroPlus & FDA NAMs
Review the 2026 landscape of PBPK modeling and MIDD. This educational report analyzes Simcyp vs GastroPlus, FDA regulatory acceptance, and animal-free NAMs.

Review the 2026 landscape of PBPK modeling and MIDD. This educational report analyzes Simcyp vs GastroPlus, FDA regulatory acceptance, and animal-free NAMs.

An in-depth review of Certara's drug development software suite for MIDD, updated for 2026. Covers Phoenix WinNonlin, Phoenix Cloud, the Simcyp PBPK Simulator, Certara IQ AI-powered QSP platform, and ICH M15 adoption.
© 2026 IntuitionLabs. All rights reserved.